{
  "cik": 1593899,
  "cik_padded": "0001593899",
  "entityName": "Atea Pharmaceuticals, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-094159",
      "filed": "2026-03-05",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 25519000.0,
        "cash": 95713000.0,
        "eps_diluted": -1.94,
        "net_income": -158349000.0,
        "operating_cash_flow": -132031000.0,
        "operating_income": -180887000.0,
        "stockholders_equity": 275434000.0,
        "total_assets": 315218000.0,
        "total_liabilities": 39784000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.14444113653361604,
        "roa_avg2y": -0.40608242743170153,
        "roa_period_end": -0.5023475816736354,
        "roe_avg2y": -0.4433677119309647,
        "roe_period_end": -0.5749072373054888
      }
    },
    {
      "accn": "0001193125-26-094159",
      "filed": "2026-03-05",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "cash": 64696000.0,
        "eps_diluted": -2.0,
        "net_income": -168385000.0,
        "operating_cash_flow": -135499000.0,
        "operating_income": -192950000.0,
        "stockholders_equity": 438867000.0,
        "total_assets": 464668000.0,
        "total_liabilities": 25801000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.05879002066685351,
        "roa_avg2y": -0.3178166842198642,
        "roa_period_end": -0.3623770089612368,
        "roe_avg2y": -0.33878270806863575,
        "roe_period_end": -0.38368116080726045
      }
    },
    {
      "accn": "0001193125-26-094159",
      "filed": "2026-03-05",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 143823000.0,
        "eps_diluted": -1.63,
        "net_income": -135956000.0,
        "operating_cash_flow": -85395000.0,
        "operating_income": -164162000.0,
        "stockholders_equity": 555192000.0,
        "total_assets": 594968000.0,
        "total_liabilities": 39776000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.07164368362656523,
        "roa_avg2y": -0.21551650344462445,
        "roa_period_end": -0.2285097685925966,
        "roe_avg2y": -0.22739604135933178,
        "roe_period_end": -0.2448810501592242
      }
    },
    {
      "accn": "0000950170-25-034808",
      "filed": "2025-03-06",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 188460000.0,
        "eps_diluted": -1.39,
        "net_income": -115909000.0,
        "operating_cash_flow": -120982000.0,
        "operating_income": -130650000.0,
        "stockholders_equity": 640572000.0,
        "total_assets": 666708000.0,
        "total_liabilities": 26136000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.04080103407579476,
        "roa_avg2y": -0.16102945262572937,
        "roa_period_end": -0.17385272113128983,
        "roe_avg2y": -0.17163452532819407,
        "roe_period_end": -0.18094609193033726
      }
    },
    {
      "accn": "0000950170-24-022226",
      "filed": "2024-02-28",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 764375000.0,
        "eps_diluted": 1.37,
        "net_income": 121190000.0,
        "operating_cash_flow": -87005000.0,
        "operating_income": 138377000.0,
        "stockholders_equity": 710077000.0,
        "total_assets": 772892000.0,
        "total_liabilities": 62815000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.08846223719399446,
        "roa_avg2y": 0.14810659666463796,
        "roa_period_end": 0.15680069142907418,
        "roe_avg2y": 0.19268959310839365,
        "roe_period_end": 0.17067163138645525
      }
    },
    {
      "accn": "0001564590-22-007672",
      "filed": "2023-02-28",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 850117000.0,
        "eps_diluted": -0.51,
        "net_income": -10947000.0,
        "operating_cash_flow": 296734000.0,
        "operating_income": -11030000.0,
        "stockholders_equity": 547801000.0,
        "total_assets": 863632000.0,
        "total_liabilities": 315831000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5765433067847631,
        "roa_avg2y": -0.02471929141192609,
        "roa_period_end": -0.012675537729032736,
        "roe_avg2y": -0.04394356020311904,
        "roe_period_end": -0.019983534166604297
      }
    },
    {
      "accn": "0000950170-23-005186",
      "filed": "2023-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "cash": 21661000.0,
        "eps_diluted": -1.39,
        "net_income": -14034000.0,
        "operating_cash_flow": -12829000.0,
        "operating_income": -14608000.0,
        "stockholders_equity": -49571000.0,
        "total_assets": 22073000.0,
        "total_liabilities": 2530000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.6357993929234812,
        "roe_avg2y": 0.3273923389166239
      }
    },
    {
      "accn": "0001564590-22-007672",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "cash": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "cash": 34492000.0,
        "net_income": -9064000.0,
        "operating_cash_flow": -7908000.0,
        "operating_income": -9477000.0,
        "stockholders_equity": -36161000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.2847091343133559
      }
    },
    {
      "accn": "0001564590-21-016724",
      "filed": "2021-03-30",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -27511000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-094159",
    "filed": "2026-03-05",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001593899.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001593899.json"
  },
  "ticker": "AVIR"
}